| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2006 | EP0966536B1 Factor x analogues with a modified protease cleavage site |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | EP0848614B1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 04/26/2006 | CN1764720A Coding calicheamicin biosynthesis and micromonospora echinospora gene for same antagonism |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1764668A Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| 04/26/2006 | CN1764662A Cyclic benzimidazoles. |
| 04/26/2006 | CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 04/26/2006 | CN1764660A Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 04/26/2006 | CN1764659A Prostaglandin analogs as EP4 receptor antagonists |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764653A FKI-1366 substance and its production |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764649A Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 04/26/2006 | CN1764647A Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 04/26/2006 | CN1764645A Oxamide derivatives useful as raf-kinase inhibitors. |
| 04/26/2006 | CN1764644A Metal ion chelators and medical use thereof |
| 04/26/2006 | CN1764640A Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with nitro compounds |
| 04/26/2006 | CN1764634A Cyclopropyl beta-amino acid derivatives |
| 04/26/2006 | CN1764477A Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 04/26/2006 | CN1764476A Composition and method for the treatment and prevention of enteric bacterial infections |
| 04/26/2006 | CN1764471A Use of chemokine receptor agonists for stem cell transplantation |
| 04/26/2006 | CN1764468A Skin protecting composition |
| 04/26/2006 | CN1764464A Tertiary amine functional complex polyester polymers and methods of production and use |
| 04/26/2006 | CN1764463A Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 04/26/2006 | CN1764462A T-type calcium channel blockers |
| 04/26/2006 | CN1764461A Estradiol metabolites for the treatment of pulmonary hypertension |
| 04/26/2006 | CN1764460A Method of treating cognitive decline due to sleep deprivation and stress |
| 04/26/2006 | CN1764459A Oral formulations |
| 04/26/2006 | CN1764458A Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 04/26/2006 | CN1764457A Combination therapy for the treatment of Alzheimer's disease |
| 04/26/2006 | CN1764456A Treatment of diseases with alpha-7nACh receptor full agonists |
| 04/26/2006 | CN1764455A Pharmaceutical composition comprising a macrolide immunomodulator. |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1764453A Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 04/26/2006 | CN1764452A Oral suspension of tegaserod |
| 04/26/2006 | CN1764451A Method for preparing 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone |
| 04/26/2006 | CN1764450A Crystalline N-formyl hydroxylamine compounds |
| 04/26/2006 | CN1764449A Preparing method of 5-methyl-N-aryl-2-pyrrolidone and 5- methyl-N-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines |
| 04/26/2006 | CN1764448A A protectant of periodontal membranes |
| 04/26/2006 | CN1764447A Use of tanshinone derivates as cholinesterase inhibitors in treating related diseases |
| 04/26/2006 | CN1764446A Drug formulations having long and medium chain triglycerides |
| 04/26/2006 | CN1764445A A method of treating breast cancer with androgen receptor antagonists |
| 04/26/2006 | CN1764444A Synergistic combinations of macrolide T-cell modulator or inmunosuppressant and a retinoid. |
| 04/26/2006 | CN1764441A Formulations comprising tolterodine and cocoa powder and use thereof |
| 04/26/2006 | CN1764440A Formulations comprising an active ingredient and cocoa powder and use thereof |
| 04/26/2006 | CN1764437A Topical pharmaceutical and/or cosmetic dispense systems |
| 04/26/2006 | CN1764432A Gargle for treating or preventing bacterial infection and fungus infection |
| 04/26/2006 | CN1764430A Kit for pharmaceutical use |
| 04/26/2006 | CN1764381A Formulations for tyrosine kinase inhibitors |
| 04/26/2006 | CN1764379A Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone |
| 04/26/2006 | CN1764378A Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 04/26/2006 | CN1764377A Preparing method of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 04/26/2006 | CN1764376A Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 04/26/2006 | CN1763075A Solasodine hydrobromate and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763074A Solasodine hydrofluoric acid salt and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763073A Solasodine hydriodate and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763069A Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/26/2006 | CN1763064A Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 04/26/2006 | CN1763057A Nucleotide analog compound |
| 04/26/2006 | CN1763056A Nucleotide analog compound |
| 04/26/2006 | CN1763046A Cephalosporin analog antibiotic preparation method |
| 04/26/2006 | CN1763030A Puerarin derivatives and their medical uses |
| 04/26/2006 | CN1763028A Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/26/2006 | CN1763027A Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/26/2006 | CN1763018A Oxazolidinone analog compound |
| 04/26/2006 | CN1763005A Preparation method and medical uses of Nú¿1ú®-hydrocarbyl-3íõ-nitrotylindirubin derivative 1 |
| 04/26/2006 | CN1763002A Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 04/26/2006 | CN1762994A Sulfonyl diphenylethyllene endocompound and its preparation method and pharmaceutical uses |
| 04/26/2006 | CN1762967A Enoxolone derivative, preparation method and uses |
| 04/26/2006 | CN1762961A Quinone compounds and its preparation method and antineoplastic use |
| 04/26/2006 | CN1762951A Compounds for the suppression of HIV TAT transactivation |
| 04/26/2006 | CN1762937A Yellow rice wine legs utilization method |
| 04/26/2006 | CN1762495A Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
| 04/26/2006 | CN1762494A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 04/26/2006 | CN1762493A Process for preparing compound aminophylline tablet |
| 04/26/2006 | CN1762487A IL-2 precursor liposome and its preparation method |
| 04/26/2006 | CN1762440A Medicine for preventing and treating cardiovascular and cerebrovascular diseases |
| 04/26/2006 | CN1762435A Red peony root medicinal wine for injury |
| 04/26/2006 | CN1762433A Novel medicinal formula for treating bone fracture and its preparation method |
| 04/26/2006 | CN1762423A Foot smell removing Chinese medicine |
| 04/26/2006 | CN1762407A Method for preparing Chinese medicinal formulation to prevent and treat apoplexy |
| 04/26/2006 | CN1762399A American ginseng effervescence tablet and its preparation method |
| 04/26/2006 | CN1762397A Photocatalyst anti-inflammation antibacterial medicinal ointment and its preparation method |
| 04/26/2006 | CN1762390A Burn and boil medicine and its preparation method |
| 04/26/2006 | CN1762388A Tasty, refreshing, sterilizing, yin-nourishing health care product or drug formula and preparation method thereof |
| 04/26/2006 | CN1762386A Bone density-increasing and senility-postponing capsule formulation |
| 04/26/2006 | CN1762385A Eye gel or in-situ gel and preparation method thereof |
| 04/26/2006 | CN1762381A Ophthalmic compositions containing galactomannan polymers and borate |
| 04/26/2006 | CN1762380A Nano selenium product and its preparation method |
| 04/26/2006 | CN1762379A Compound glucosamine sulfate dispersible tablet formulation and its preparation method |
| 04/26/2006 | CN1762378A Indian bread polysaccharide formulation and its preparation method |
| 04/26/2006 | CN1762377A Medicinal composition containing zidovudine, valproic acid or its salt |
| 04/26/2006 | CN1762376A Whitening acne-removing cream |
| 04/26/2006 | CN1762375A Erigeron breviscapus ketone ester and its injection preparation process |
| 04/26/2006 | CN1762374A Gypenosides pills formula and its preparation method |
| 04/26/2006 | CN1762373A 'Xueshuantong' soft capsule and its preparation |
| 04/26/2006 | CN1762372A 'Thrombus-removing' infusion liquid and its preparation method |
| 04/26/2006 | CN1762371A Application of stauntoniae sapoin in preparation of anti-tumor medicine |